- NEWS
Russia announces positive COVID-vaccine results from controversial trial
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
204,58 € per year
only 4,01 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-020-03209-0
What Pfizer’s landmark COVID vaccine results mean for the pandemic
Russia’s fast-track coronavirus vaccine draws outrage over safety
Who gets a COVID vaccine first? Access plans are taking shape